INTERVIEW: A Sharjah oilman’s view on the energy world

Illustration by Luis Grañena
Short Url
Updated 26 July 2020
Follow

INTERVIEW: A Sharjah oilman’s view on the energy world

  • SNOC CEO explains how US shale will be big loser from price wars

The Sharjah National Oil Co. (SNOC) is not one of the big beasts of the global oil world, certainly in comparison with its giant neighbors such as Saudi Aramco or the Abu Dhabi National Oil Co. (ADNOC). 

As the SNOC’s CEO Hatem Al-Mosa admits, its production disappears in the rounding up of the UAE’s quota at the Organization of the Petroleum Exporting Countries (OPEC).

But Al-Mosa is a lifelong oilman, having worked at Amoco and then BP after the two companies merged, and he has a wealth of experience and insight into the business.

A conversation with him is well worth having for anybody seeking an expert view on what is happening in the energy world.

So who better to ask the burning questions of the last five months of unprecedented turbulence and volatility in the global energy business: Has there been a price war? And who won it?

 

On the latter, he is adamant. “Nobody won. Everybody lost very badly,” he told Arab News. “My perception is that what happened is that Russia didn’t want to continue playing with the production cuts. Saudi Arabia could at that moment have decided, ‘OK, Russia doesn’t want to play, we’ll also stop playing and we’ll continue from where we’ve stopped’,” he said.

“That wouldn’t have caused the huge crash that happened at that moment when Saudi Arabia decided to completely abandon the cuts and go for full production.”

But that was not the main reason oil prices collapsed in April. “Russia definitely didn’t want to cooperate, but didn’t have to go to that extreme,” Al-Mosa said.

“However what they all didn’t anticipate was (the coronavirus disease) COVID-19. It was in play, but COVID-19 wasn’t yet seen as a demand destroyer.”

But the big loser, he believes, has been US shale. The collapse of the oil price — the American benchmark West Texas Intermediate went into negative territory on Black Monday in April — meant that many US shale companies were no longer financially viable, and there has been a slate of bankruptcies and shut-ins since. Al-Mosa saw it coming.

 

“From the moment it started, I thought shale oil was going to be the biggest victim of the price war, but neither I nor anybody else thought the destruction was going to be so severe because of COVID-19. It was the perfect storm, and it just destroyed everything,” he said.

In some ways, shale had it coming. “If you look at history, before shale oil OPEC pretty much controlled prices. They tried to increase and reduce supply to have a cost matched to demand at a comfortable price for OPEC,” he said.

“Once shale oil came into the picture at the beginning of the 21st century, that formula has essentially gone away because every time OPEC ceded production to control price, shale oil went and grabbed that share.”

The price collapse in April was a reckoning. “Shale oil played in a very irresponsible manner. They were just completely driven by money, and every time there was a chance they’d grab another piece of the market share and OPEC lost some more production,” Al-Mosa said.


BIO

BORN: Kuwait 1962

EDUCATION

  • BSc chemical engineering, University of Illinois
  • MSc chemical engineering, Carnegie Mellon University

CAREER

  • Plant engineer, Amoco
  • Chief process engineer, BP-Amoco
  • Technical control manager, SNOC
  • CEO, SNOC
  • Secretary-general, Sharjah Petroleum Council

Does he think, as some experts have suggested, that Saudi Arabia planned to drive shale out of the market?

“It’s purely speculation on my side, whatever I say. I think if it was intentional on their side that was pretty smart, but they can’t say that because it would upset politicians in the US, so they could easily blame it on COVID-19 and Russia,” he said.

Some analysts have said Saudi Arabia needs to get oil prices as high as possible as soon as possible, but Al-Mosa believes a more measured approach is needed.

“People keep saying we should recover the oil price, but I think that shouldn’t be OPEC’s priority. It should be to maintain a price of $35-$45 and instead recover market share,” he said.

“Every time the price starts edging toward $45, they should be increasing production, reducing the cuts, and they should continue doing that to prevent oil going above $45 until they recover 100 percent of the cuts.”

The future path of the oil market depends on the relationship between Saudi Arabia and Russia, which are the main architects of the OPEC+ deal, which lays great emphasis on compliance — by all OPEC+ participants — with the new production levels.

“If Russia sees that Saudi Arabia is cutting too much and wants to get to $50, there’s a chance Russia will say, ‘No, I don’t want $50, I want market share back,” Al-Mosa said.

 

“If there’s any weakening in the Russia-Saudi agreement, it will encourage other smaller countries that are suffering in the cuts to pull out too,” he added.

“So I think the unity of OPEC+ is very crucial in the coming phase to keep stability in the market and the oil price, but also to be flexible enough to reduce the cuts as the oil price starts to recover.”

Outside the OPEC+ agreement, Al-Mosa sees a looming investment gap as independent oil companies, as well as national ones, cut back capital investment.

“Capital budgets have been cut so severely across all the NOCs (national oil companies) and IOCS (international oil companies) to the point where if demand comes back to where it was before COVID-19, OPEC+ won’t have the production to meet it,” he said.

“It will be worse one year from now if they don’t spend money today, and even worse two years from now. I expect by the end of next year there could be a big spike in the oil price.”

The big imponderable for the global energy industry is demand — how quickly can the big economies of the world reopen after the pandemic lockdowns, and recover the level of roughly 100 million barrels per day of demand that was the norm before the pandemic? Al-Mosa is not especially optimistic on that front.

 

“I don’t see any long-term recovery coming soon. There will be ups and downs along the way, but I think we’re very far away from a real recovery,” he said.

“COVID-19 isn’t going away anytime soon, and it’s just getting worse … everywhere in the world, with big economies like India, the US, Brazil, Russia. It’s also spreading in other places that have weaker reporting, like Africa.”

Al-Mosa believes that regional policymakers have to strike a fine balance in terms of economic stimulus packages to combat the virus, and is critical of the Saudi decision to triple the level of value-added tax (VAT).

“Raising VAT may get money faster to the government, but I think long term it will actually be worse because it hurts business and that revenue source will drop,” he said.

Al-Mosa does not subscribe to the beliefs of some global leaders who have minimized the effects of the virus.

“Some people mistake the reopening as a sign that the danger from COVID-19 is less than it was before, or that the virus is getting weaker. That’s all false propaganda and misinformation. The virus didn’t get any weaker. It’s as deadly as it was from day one,” he said.

But he thinks leaders in the Middle East have set a good example. “Throughout the reopening, we’re asking people to wear masks all the time, and we see our leaders wearing masks,” he said.

“There’s a consistent message that COVID-19 isn’t a safe game, it’s a very deadly pandemic, but you can combat it by taking simple precautionary measures,” he added.

“If our leaders don’t play this role, and they say it’s just another flu or something like this, it will encourage bad behavior.”

The SNOC is part of the wider UAE economy, and although Sharjah does not play a large role in that oil-dominated structure, it has inevitably been affected by the fall in the world’s oil prices and the resulting global economic downturn.

But it has managed to keep to an expansion strategy that was in place before the pandemic hit.

“We haven’t cut back any people during the pandemic. In fact, we’ve actually hired a few people,” Al-Mosa said.

“Before the pandemic, we were in expansion mode and had initiated several projects, major by our standards, though they may not be major on ADNOC’s scale. We were already moving ahead,” he added.

“The only impact has been that we slowed down a little bit on the execution of some of them, and we’ve implemented very strict measures to protect the workforce. Essentially all of the company’s workforce, except operations, began working from home. But operations continued 24 hours a day, non-stop.”


AI’s shift toward proactive healthcare

Updated 05 February 2026
Follow

AI’s shift toward proactive healthcare

  • Experts reveal how AI is reducing burnout and streamlining workflows

JEDDAH: Artificial intelligence is increasingly moving from the margins of healthcare innovation into its operational core. Rather than replacing clinicians, AI is being deployed to address persistent challenges across health systems, from administrative overload and staff burnout to fragmented data and inefficient patient flow.

Speaking to Arab News, Abbes Seqqat, chief executive officer of Rain Stella Technologies, and Eric Turkington, chief product officer, discussed how AI is already transforming healthcare delivery — and why its impact is most meaningful when embedded directly into clinical workflows rather than treated as a standalone tool.

Seqqat describes AI’s role as accelerating a structural shift in healthcare delivery. “AI is accelerating the shift in healthcare from reactive to proactive care, because AI fundamentally helps detect, analyze and predict,” he said, noting that many health systems lack the resources to perform these tasks at scale.

Abbes Seqqat, chief executive officer of Rain Stella Technologies. (RST photo)

While AI use cases in healthcare are broad, Seqqat emphasized that the most effective applications today focus on operational and clinical fundamentals, including reducing administrative burden, identifying patient risks earlier, and capturing clinical data more reliably and in real time.

RST’s portfolio reflects this approach, spanning surgical data capture and workflow automation, cloud-based electronic medical records, and health information exchange. Across these systems, the common goal is improving data quality and usability so clinicians can spend less time managing information and more time delivering care.

According to Turkington, RST’s systems rely on a mix of established and emerging AI technologies.

RST's Equinox offers a streamlined workflow, minimizing redundant data entry, and also allows for seamless integration with other systems. (RST images)

“Across the portfolio, we are using a wide range of AI and predictive technologies, from voice technology to reliably capture clinician inputs, to large language models that analyze and act on collected data,” he said.

A key focus has been adapting AI to regional and clinical realities. Voice models, for example, have been trained on UAE and GCC accents and grounded in medical terminology to improve accuracy in real-world settings. RST also uses retrieval-augmented generation and multi-agent AI architectures, allowing different AI components to perform specialized tasks such as classifying surgical notes, identifying unusual events, or assisting with billing and coding, Turkington explained.

DID YOU KNOW?

• AI can detect, analyze, and predict patient risks faster than traditional methods.

• Systems like Equinox use voice input and predictive analytics to actively support clinical decisions.

• AI assistants provide real-time updates, automate documentation, and improve coordination in operating theaters.

One of the central concerns around AI adoption is whether it adds complexity to already demanding clinical roles. Seqqat argues the opposite should be the goal.
“For nurses and frontline staff, AI’s greatest contribution is removing the invisible administrative friction that leads to burnout,” Seqqat said.

In operating theaters, AI systems can replace manual coordination methods such as phone calls and whiteboards by providing real-time situational awareness. By automating updates, anticipating delays, and serving as an on-demand clinical notepad, AI reduces cognitive load and allows staff to remain focused on patient care, he explained.

RST’s voice-enabled assistant, Orva, is designed specifically for perioperative environments.

Orva captures live updates through voice input, enabling it to surface delays, flag bottlenecks, and prompt coordination between departments. (RST photo)

Turkington said it enables hands-free documentation and coordination, helping surgical teams manage schedules and resources more effectively.

By capturing live updates through voice input, Orva can surface delays, flag bottlenecks, and prompt coordination between departments. It also assists with documentation and coding, reducing errors and supporting more accurate reimbursement— an area where incomplete records often create downstream challenges.

Electronic medical records remain central to healthcare delivery, but Turkington noted that AI can move them beyond passive data repositories.

Eric Turkington, chief product officer of Rain Stella Technologies. (RST photo)

“We designed Equinox as an EMR that enables you to spend less time with the software and more time with patients,” Turkington said.

Through voice input, automated documentation from visual annotations, and AI-generated pre-visit summaries, the system can actively support clinicians rather than slow them down. Predictive analytics, such as identifying no-show risks or highlighting care gaps, further shift EMRs toward decision-support tools rather than administrative obligations.

Both executives stressed that AI’s effectiveness depends heavily on data access and quality. Seqqat pointed to interoperability as a prerequisite rather than an afterthought.
“AI is only as powerful as the data it can access,” he said, adding that fragmented records limit both clinical insight and system-wide learning.

Health information exchanges, such as RST’s Constellation platform, enable patient data to be viewed longitudinally across providers. AI can then assist with patient identity matching and population-level analysis, allowing trends and risks to be identified across large datasets.

Turkington shared an example from an operating theatre where AI helped prevent cascading delays. When a surgical case ran late, a nurse verbally updated Orva that the patient was ready to exit. The system alerted the recovery unit, analyzed schedule conflicts, and prompted management to reassign staff before delays affected subsequent procedures.

Opinion

This section contains relevant reference points, placed in (Opinion field)

By tagging the cause of the delay and feeding that data into predictive models, the system helped prevent similar issues in the future — without additional manual coordination.

According to Seqqat, the primary returns from AI adoption come from combining efficiency with financial accuracy. Streamlined workflows allow providers to treat more patients without compromising care, while improved documentation reduces revenue leakage.

Looking ahead, Seqqat sees AI becoming central to Saudi Arabia’s healthcare transformation. He described its role as advancing smart hospitals, predictive patient flow, and precision medicine aligned with Vision 2030 goals.
“The role of AI in Saudi Arabia’s healthcare sector is evolving from a supporting technology to a foundational pillar of the Kingdom’s Vision 2030 transformation. Over the next few years, we expect to see AI move into the realm of smart hospitals, where predictive analytics optimize patient flow and AI-driven precision medicine leverages the Saudi Genome Program to provide hyper-personalized care. By unifying national health data and automating complex administrative workflows, AI will enable a more proactive, value-based healthcare model that improves patient outcomes and operational efficiency across the country.”